Researchers identified corticosterone-mediated neuron–microglia interactions following ketamine anesthesia, which are ...

GLP-1 drugs may influence cancer risk by reversing obesity-related metabolic dysfunction and inflammation. Researchers are ...

Two studies mapped the structures of VPS13 proteins associated with neurodegenerative diseases, laying the groundwork for understanding how mutations disrupt cellular lipid transport.

New research identified a previously unknown type of brain plaque that may emerge at the earliest stages of Alzheimer's disease. The mitochondrial plaques offer a new potential therapeutic target.

As cell therapies move into broader disease areas, developers face increasing pressure to demonstrate manufacturing readiness. John Tomtishen discusses why CMC considerations are shifting from a ...

A case series showed that combining phage therapy with fecal microbiota transplantation may help control recurrent urinary tract infections in women, reducing reliance on antibiotics.

Restoration of BMP3 protein reversed pulmonary vascular remodeling and improved cardiac function in preclinical models of pulmonary arterial hypertension. Results were consistent across gene therapy ...

Researchers developed a modified DNA platform designed to reduce innate immune activation while maintaining gene expression. The approach could provide durable, redosable genetic therapies without the ...

Technology Networks spoke with PacBio's Amit Patel and Covaris' Greg Endress about how integrated extraction, library preparation, and HiFi sequencing workflows are unlocking new opportunities for ...

SLIM technology can drastically increase the available flight path for ion mobility separation, revealing previously hidden data. Hear from experts at MOBILion Systems on how this technology could ...

Data silos in bioprocessing limit quality, compliance, and operational efficiency. Cloud-based LIMS–MES integration can create a single source of data, enabling better traceability, faster batch ...

Edwin Hauw and Tilmann Burckstummer discuss how automation and multimodal analysis are addressing long-standing limitations of optical pooled screening, enabling more scalable and informative CRISPR ...